dihydroergocryptine has been researched along with fenofibrate in 1 studies
| Studies (dihydroergocryptine) | Trials (dihydroergocryptine) | Recent Studies (post-2010) (dihydroergocryptine) | Studies (fenofibrate) | Trials (fenofibrate) | Recent Studies (post-2010) (fenofibrate) |
|---|---|---|---|---|---|
| 21 | 8 | 2 | 3,058 | 529 | 1,354 |
| Protein | Taxonomy | dihydroergocryptine (IC50) | fenofibrate (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.371 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.701 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.118 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.371 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 8.633 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 1 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burhenne, J; Ehrhardt, M; Haefeli, WE; Lindenmaier, H; Weiss, J | 1 |
1 other study(ies) available for dihydroergocryptine and fenofibrate
| Article | Year |
|---|---|
Influence of lipid lowering fibrates on P-glycoprotein activity in vitro.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Dihydroergocryptine; Fenofibrate; Humans; Hypolipidemic Agents; Simvastatin; Swine; Transfection | 2004 |